Barclays Raises Ares Management (NYSE:ARES) Price Target to $174.00
Ares Management (NYSE:ARES – Free Report) had its price target boosted by Barclays from $155.00 to $174.00 in a report released on Monday, Benzinga reports. The brokerage currently has an overweight rating on the asset manager’s stock. A number of other research analysts have also commented on the company. Deutsche Bank Aktiengesellschaft cut their target […]
Barclays Cuts HF Sinclair (NYSE:DINO) Price Target to $44.00
HF Sinclair (NYSE:DINO – Free Report) had its price objective trimmed by Barclays from $53.00 to $44.00 in a report published on Monday, Benzinga reports. The firm currently has an equal weight rating on the stock. A number of other analysts also recently weighed in on the stock. BMO Capital Markets decreased their target price […]
Barclays Raises WEC Energy Group (NYSE:WEC) Price Target to $89.00
WEC Energy Group (NYSE:WEC – Get Free Report) had its price target upped by research analysts at Barclays from $86.00 to $89.00 in a report released on Monday, Benzinga reports. The brokerage currently has an “underweight” rating on the utilities provider’s stock. Barclays‘s target price would suggest a potential downside of 5.67% from the company’s […]
Capital One Financial (NYSE:COF) Given New $158.00 Price Target at Barclays
Capital One Financial (NYSE:COF) had its price objective lifted by equities research analysts at Barclays from $154.00 to $158.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s price target indicates a potential upside of 4.08% from the stock’s current […]
Barclays Boosts CME Group (NASDAQ:CME) Price Target to $219.00
CME Group (NASDAQ:CME – Get Free Report) had its price target hoisted by analysts at Barclays from $209.00 to $219.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the financial services provider’s stock. Barclays‘s price target would suggest a potential downside of 1.21% […]
Barclays Boosts The Carlyle Group (NASDAQ:CG) Price Target to $50.00
The Carlyle Group (NASDAQ:CG – Free Report) had its price target hoisted by Barclays from $46.00 to $50.00 in a report released on Monday, Benzinga reports. The firm currently has an overweight rating on the financial services provider’s stock. Several other equities analysts have also commented on CG. Redburn Atlantic initiated coverage on shares of […]
Barclays Lowers F&G Annuities & Life (NYSE:FG) Price Target to $44.00
F&G Annuities & Life (NYSE:FG – Get Free Report) had its price target decreased by stock analysts at Barclays from $45.00 to $44.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential upside of 2.42% from the […]
Barclays Boosts Nasdaq (NASDAQ:NDAQ) Price Target to $84.00
Nasdaq (NASDAQ:NDAQ – Free Report) had its target price upped by Barclays from $77.00 to $84.00 in a report issued on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the financial services provider’s stock. Several other equities research analysts have also issued reports on NDAQ. Oppenheimer lifted their price target on shares […]
Barclays Lowers LyondellBasell Industries (NYSE:LYB) Price Target to $99.00
LyondellBasell Industries (NYSE:LYB – Get Free Report) had its price objective cut by equities research analysts at Barclays from $101.00 to $99.00 in a report issued on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective would suggest a potential upside of 5.21% from […]
Barclays Increases Bristol-Myers Squibb (NYSE:BMY) Price Target to $43.00
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its price target lifted by Barclays from $42.00 to $43.00 in a report issued on Monday, Benzinga reports. They currently have an underweight rating on the biopharmaceutical company’s stock. BMY has been the subject of several other research reports. TD Cowen raised their target price on Bristol-Myers Squibb […]
Barclays Raises Cboe Global Markets (BATS:CBOE) Price Target to $239.00
Cboe Global Markets (BATS:CBOE – Get Free Report) had its price target lifted by equities researchers at Barclays from $218.00 to $239.00 in a report released on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would suggest a potential upside of 15.12% from the stock’s current price. […]
TFI International (NYSE:TFII) Price Target Cut to $181.00
TFI International (NYSE:TFII – Get Free Report) had its price objective dropped by JPMorgan Chase & Co. from $184.00 to $181.00 in a report issued on Tuesday, BayStreet.CA reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 33.07% from the stock’s […]
Ryan Berry Sells 20,000 Shares of Ares Management Co. (NYSE:ARES) Stock
Ares Management Co. (NYSE:ARES – Get Free Report) insider Ryan Berry sold 20,000 shares of the stock in a transaction that occurred on Friday, October 4th. The shares were sold at an average price of $160.07, for a total value of $3,201,400.00. Following the transaction, the insider now owns 344,202 shares in the company, valued […]
last updated on 10 Oct 11:18